Guangzhou Red Pine Medical Instrument Co., Ltd. appears in FDA records as the applicant for single-use video flexible ureterorenoscope submissions, including model families RP-U-C06R9, RP-U-C06R3, RP-U-C06S9 and RP-U-C06S3 under K262488, and RP-U-C03R9, RP-U-C03R3, RP-U-C03S9 and RP-U-C03S3 under K251951. The company's own website describes it as a supplier of single-use endoscopy solutions and lists urology among its product areas. [1][6][3]
Documented FDA submissions
K262488 covers a Single-Use Video Flexible Ureterorenoscope under the model designations RP-U-C06R9, RP-U-C06R3, RP-U-C06S9 and RP-U-C06S3. The filing records a Traditional clearance type, product code FGB, regulation number 876.1500, advisory committee GU, a receipt date of 20 July 2026 and a decision date of 9 September 2026 with decision code SESE, described as Substantially Equivalent. The submission is listed with a Summary rather than a statement. [1]
An earlier clearance, K251951, was issued 16 December 2025 for a Single-Use Video Flexible Ureterorenoscope (RP-U-C03R9, RP-U-C03R3, RP-U-C03S9, RP-U-C03S3) together with Endoscopic Video Image Processor RP-IPD-V2000EF and Endoscopic Video Image Processor RP-IPD-V1000F. The FDA letter names Ping Yang as Regulatory Affairs Manager and cites the same regulation, 21 CFR 876.1500. [6][7]
Product scope and technology
The ureteroscope line is classified as Ureteroscope And Accessories, Flexible/Rigid, device class 2, with medical specialty descriptions of Gastroenterology and Urology. The K251951 review document records an outer diameter of the flexible insertion portion of Φ2.50 mm (7.5 Fr) for the RP-U-C03 models, with Φ2.9 mm (8.7 Fr) for RP-U-C12 and Φ2.85 mm (8.6 Fr) for RP-U-C0304 and RP-U-C0305. [1][6]
The company's website lists single-use video flexible rhinolaryngoscope RP-E-C02 alongside single-use video cystoscope, hysteroscope, flexible choledochoscope and gastroscope offerings, and describes itself as a global supplier of single-use endoscopy solutions. The site states the company was established in 2015 and describes work in single-use endoscopes, medical endoscope image processors and single-use intraoperative instruments. [3][5]
Applicant identity and filing address
FDA filings give the applicant address as 12 F, #87 Luoxuan Ave., Guangzhou International Bioisland, Guangzhou, postal code 510000, country CN, with contact Weihua Yang on K262488. The company website lists 12F, NO.87 Luoxuan Avenue, Guangzhou International Bioisland as its address. These are filing and contact addresses; no parent company, brand ownership or corporate headquarters is verified in the public documents. [1][3]
What the record shows and does not show
The supplied collection contains one linked 510(k) record, K262488, with a decision count of one SESE, and the record sample holds that same single entry. These counts describe the supplied filings as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. No recall records appear in the supplied sample. [1]
The website describes the company as dedicated to becoming an internationally leading disposable endoscope platform enterprise and refers to integrated manufacturing. Those are company-published statements; independent verification, customer lists, certifications and commercial availability outside the cited filings are not established by the public documents. [3][5]

